Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E

Pei-Hsin Cheng1, Xiao-Mei Rao, Kelly M McMasters

  • 1Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.

Plos One
|February 26, 2013
PubMed

Insights

Adenoviruses lacking E1b55K replicate in cancer cells by activating cyclin E/CDK2. This complex phosphorylates pRb, promoting viral replication and aiding oncolytic virotherapy development.

Area of Science:

  • Oncolytic virotherapy
  • Molecular biology
  • Cancer research

Background:

  • Adenoviruses (Ads) with E1b55K deletion show oncolytic potential, preferentially replicating in cancer cells.
  • Previous work linked Ad E1B55K protein to cyclin E induction for viral replication, a function less critical in cancer cells with deregulated cyclin E.

Purpose of the Study:

  • To investigate the interaction between cyclin E and CDK2 in Ad-infected cells.
  • To elucidate the role of the cyclin E/CDK2 complex in Ad replication within cancer cells.

Main Methods:

  • Studied Ad-infected cells to analyze cyclin E forms and CDK2 activity.
  • Utilized roscovitine and small interfering RNAs to inhibit CDK2 activity.
  • Assessed pRb phosphorylation and viral replication rates.

Main Results:

  • Ad infection increased large cyclin E (cyclin EL) and cyclin E/CDK2 complex formation.
  • CDK2 phosphorylation at T160 and subsequent pRb phosphorylation at S612 were observed.
  • CDK2 inhibition significantly reduced pRb phosphorylation and viral replication.

Conclusions:

  • Ad-induced cyclin E activates CDK2, which phosphorylates pRb, creating a favorable cellular environment for viral replication.
  • This mechanism provides a molecular basis for the oncolytic replication of E1b-deleted Ads.
  • Findings support the development of novel Ad-based oncolytic virotherapies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...